Licorice isoliquiritigenin-encapsulated mesoporous silica nanoparticles for osteoclast inhibition and bone loss prevention

Xiaoyue Sun, Jie Zhang, Zijun Wang, Bingqian Liu, Shenting Zhu, Lingxin Zhu, Bin Peng

Theranostics · 2019 · 68 citations · 39 references

DOIFull text

Open access

Concepts

Abstract

: Licorice ISL-encapsulated MSNs exhibit notable anti-osteoclastogenetic effects and protect against inflammatory bone destruction. Our findings reveal the feasibility of applying MSNs-ISL as an effective natural product-based bone-bioresponsive nanoencapsulation system to prevent osteoclast-mediated bone loss.

References

39